조영민 박사
MD, PhD
내분비내과학
Smart Management of Diabetes/Obesity
[학력]
1996년 서울의대 졸업
2000년 서울의대 내과학 석사
2004년 서울의대 내과학 박사
[경력]
1996-2000 서울대병원 인턴 및 내과 레지던트
2001-2002 서울대병원 내분비내과 전임의
2003-2004 서울대병원 내분비내과 임상전임강사
2004-2010 서울대병원 내분비내과 임상교수
2009-2010 Visiting Professor, University of British Columbia (Canada)
2010-현재 서울대학교 의과대학 내과학교실 조교수/부교수/교수
2016-현재 한국건강관리협회 이사
2018-2019 대한당뇨병학회 총무이사
2020-2023 서울대학교병원 내과 내분비대사내과 분과장
2022-2023 대한당뇨병학회 연구이사
2023-2024 대한내분비학회 학술이사
2023-현재 서울대학교병원 기획조정실장/병원관리지원실장
"스마트 디바이스를 이용한 혈당 관리"
"Blood Glucose Management Using Smart Devices"
학습목표(Learning Objectives)
스마트 디바이스를 이용한 당뇨 관리 시스템의 효과를 이해한다.
간헐적 연속 혈당 모니터링(isCGM)과 이를 활용한 환자 주도 생활습관 개선의 효과를 설명한다.
스마트 디바이스를 활용한 맞춤형 당뇨 관리 전략을 설계할 수 있다.
Understand the effectiveness of smart device-based diabetes management systems.
Explain the effects of intermittently scanned continuous glucose monitoring (isCGM) and patient-driven lifestyle modifications.
Design personalized diabetes management strategies using smart devices.
초록(Abstract)
Recent advancements in diabetes care emphasize the role of technology in enhancing patient-centered management. This lecture explores how smartphone-based systems and continuous glucose monitoring (CGM) devices can improve glycemic control in individuals with type 2 diabetes (T2D). Based on my previous two studies, I will examine the impact of integrated smart devices integration on diabetes outcomes.
The first study highlights a 24-week randomized controlled trial of the mDiabetes system, which incorporates glucose monitoring, diet, physical activity tracking, and clinical decision support. The trial demonstrated that patients using mDiabetes showed a significantly greater reduction in HbA1c compared to those using traditional paper logbooks (−0.40% vs. −0.06%). Additionally, the proportion of patients achieving HbA1c levels below 7.0% was notably higher in the mDiabetes group, with an odds ratio of 2.01.
The second study focuses on patient-driven lifestyle modification using intermittently scanned CGM (isCGM) over 12 weeks. Participants receiving the structured education, aided by the SEOUL algorithm, showed an HbA1c reduction of −0.50% compared to the standard care. This intervention also led to improvements in fasting blood glucose, body weight, and self-care activities, with no reported severe hyperglycemia or hypoglycemia.
Through these studies, I will discuss the potential of smart devices promoting patients’ proactive diabetes management, highlighting their abilities to support personalized interventions, improve glycemic control, and enhance patient engagement.